What AI dreams up when you type in “battery anode.” Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Evolution Energy (ASX:EV1) has announced the results of testwork on battery anodes made from its graphite ore at Chilalo as “successful.”

The company had a third party entity called BTR to run testwork on bulk concentrate samples from EV1’s Chilalo project.

The potential upside for EV1 holders?: “testwork has confirmed the ability for Chilalo graphite to replicate BTR’s existing premium quality anode materials mass produced by BTR.”

Graphite needs to be spherised at as pure grades as possible before it is converted into a foil – generally in China – which then goes into lithium-ion batteries.

The testwork ultimately forms an early-stage due diligence process ahead of a binding offtake agreement to be inked between BTR and EV1.

““Following the successful due diligence testwork by BTR, this program has sought to advance into the next phase – qualifying Chilalo anode materials into BTR’s premium quality product specifications,” EV1 MD Phil Hoskins said.

“Results of this testwork will determine the anode specifications most suitable to Chilalo concentrate.

“We are confident that anodes derived from Chilalo graphite can qualify into the supply chains of major battery and electric vehicle companies.”

EV1 reported on Monday that anodes made from its Chilalo-sourced graphite had greater compaction and exfoliation strength “than reference products.

Electrode plate rebound was also reported as increased with “long-term-performance being optimised.”

Evolution Energy Minerals shareholders are likely pleased by the news, given that returns are down nearly -70% YoY – despite a bull run on graphite stocks triggered late last year when news of a Chinese graphite export ban hit the international markets.

EV1 last traded at 7.4cps.

ev1 by the numbers
More From The Market Online

KGL Resources jumps 25% on US$300M funding deal

KGL Resources has entered into a US$300 million PMPA to help fund construction and development of…
London

With osteo Phase 3 trial at 50% recruitment, Paradigm Bio inks partnership with University of London

Paradigm Biopharma (ASX:PAR) has this week hit two big items out the park: first of all, hitting 50% recruitment

Terra hits multiple intersections at Southwest SW6 prospect; assays now due in next ~12 weeks

Terra Metals has hit multiple intersections of massive sulphides in drilling at the Southwest SW6 prospect…
Easter bunny in a business suit analyzing stock charts, symbolizing market strategy

ASX closed for Easter long weekend. Enjoy your chocolates and the holiday break!

Yes, yes, I know you’re itching to do some serious Australian market trading today, but everyone — especially our much-loved HotCopper forum users